Washington, DC 20006-5349
HELPLINE
SAVE THE DATE
June 23-25, 2011 in Washington, DC. For more information visit curemeso.org/symposium. Stay tuned…
Mental health is a big issue for mesothelioma patients, caregivers, and family members. This session covers how patients as well as their loved ones can
CAR-T (Chimeric antigen receptor) cell therapy is a type of immunotherapy that uses a patient’s T cells to attack cancer cells. T cells are white
For patients with MPM (Malignant Pleural Mesothelioma), the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab) as a first-line treatment when combined with
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
